-
1
-
-
0036894736
-
Valvular heart disease in patients taking pergolide
-
Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE: Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77: 1280-1286
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 1280-1286
-
-
Pritchett, A.M.1
Morrison, J.F.2
Edwards, W.D.3
Schaff, H.V.4
Connolly, H.M.5
Espinosa, R.E.6
-
2
-
-
0036894735
-
Drug-related valvular heart disease: Here go again: Will we do better this time?
-
Rahimtoola SH: Drug-related valvular heart disease: Here go again: Will we do better this time? Mayo Clin Proc 2002; 77: 1275-1277
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 1275-1277
-
-
Rahimtoola, S.H.1
-
3
-
-
0038581961
-
The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease
-
Rowers CM, Racoosin JA, Lu SL, Beitz JG: The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease. Mayo Clin Proc 2003; 78: 730-731
-
(2003)
Mayo Clin Proc
, vol.78
, pp. 730-731
-
-
Rowers, C.M.1
Racoosin, J.A.2
Lu, S.L.3
Beitz, J.G.4
-
4
-
-
0038388798
-
Additional insights into pergolide-associated valvular heart disease
-
Lanier WL: Additional insights into pergolide-associated valvular heart disease. Mayo Clin Proc 2003; 78: 684-686
-
(2003)
Mayo Clin Proc
, vol.78
, pp. 684-686
-
-
Lanier, W.L.1
-
5
-
-
11144354035
-
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
-
Van Camp G, Flamez A, Cosyns B, Weytjens C, Muyldermans L, Van Zandijcke M, De Suiter J, Santens P, Decoodt P, Moerman C, Schoors D: Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004; 363: 1179-1183
-
(2004)
Lancet
, vol.363
, pp. 1179-1183
-
-
Van Camp, G.1
Flamez, A.2
Cosyns, B.3
Weytjens, C.4
Muyldermans, L.5
Van Zandijcke, M.6
De Suiter, J.7
Santens, P.8
Decoodt, P.9
Moerman, C.10
Schoors, D.11
-
6
-
-
3242763710
-
Pergolide use in Parkinson disease is associated with cardiac valve regurgitation
-
Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB Jr: Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. Neurology 2004; 63: 301-304
-
(2004)
Neurology
, vol.63
, pp. 301-304
-
-
Baseman, D.G.1
O'Suilleabhain, P.E.2
Reimold, S.C.3
Laskar, S.R.4
Baseman, J.G.5
Dewey Jr., R.B.6
-
7
-
-
0141653014
-
Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide
-
Van Camp G, Flamez A, Cosyns B, Goldstein J, Perdaens C, Schoors D: Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide. Neurology 2003; 61: 859-861
-
(2003)
Neurology
, vol.61
, pp. 859-861
-
-
Van Camp, G.1
Flamez, A.2
Cosyns, B.3
Goldstein, J.4
Perdaens, C.5
Schoors, D.6
-
8
-
-
4444351812
-
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
-
Horvath J, Fross RD, Kleiner-Fisman G, Lerch R, Stalder H, Liaudat S, Raskoff WJ, Flachsbart KD, Rakowski H, Fache JC, Burkhard PR, Lang AE: Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists. Movement Disorders 2004; 19: 656-662
-
(2004)
Movement Disorders
, vol.19
, pp. 656-662
-
-
Horvath, J.1
Fross, R.D.2
Kleiner-Fisman, G.3
Lerch, R.4
Stalder, H.5
Liaudat, S.6
Raskoff, W.J.7
Flachsbart, K.D.8
Rakowski, H.9
Fache, J.C.10
Burkhard, P.R.11
Lang, A.E.12
-
9
-
-
0019932339
-
Evaluation of tricuspid regurgitation by pulsed Doppler and two-dimensional echocardiography
-
Miyatake K, Okamoto M, Kinoshita N, Ohta M, Kozuka T, Sakakibara H, Nimura Y: Evaluation of tricuspid regurgitation by pulsed Doppler and two-dimensional echocardiography. Circulation 1982; 66: 777-784
-
(1982)
Circulation
, vol.66
, pp. 777-784
-
-
Miyatake, K.1
Okamoto, M.2
Kinoshita, N.3
Ohta, M.4
Kozuka, T.5
Sakakibara, H.6
Nimura, Y.7
-
10
-
-
0021355452
-
Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography
-
Mikami T, Kudo T, Sakurai N, Sakamoto S, Tanabe Y, Yasuda H: Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography. Am J Cardiol 1984; 53: 160-163
-
(1984)
Am J Cardiol
, vol.53
, pp. 160-163
-
-
Mikami, T.1
Kudo, T.2
Sakurai, N.3
Sakamoto, S.4
Tanabe, Y.5
Yasuda, H.6
-
11
-
-
0027537179
-
Edema: An infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs
-
Blackard WG: Edema: An infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. Am J Med 1993; 94: 445
-
(1993)
Am J Med
, vol.94
, pp. 445
-
-
Blackard, W.G.1
-
12
-
-
0034073543
-
Clinical characteristics of pramipexole-induced peripheral edema
-
Tan EK, Ondo W: Clinical characteristics of pramipexole-induced peripheral edema. Arch Neurol 2000; 57: 729-732
-
(2000)
Arch Neurol
, vol.57
, pp. 729-732
-
-
Tan, E.K.1
Ondo, W.2
-
13
-
-
22044452961
-
Valvular heart disease
-
(ed by Zipes DP, Libby P, Bonow RO, Braunwald E), 7th Ed. Elsevier Saunders, Philadelphia
-
Bonow RO, Braunwald E: Valvular heart disease, in Heart Disease (ed by Zipes DP, Libby P, Bonow RO, Braunwald E), 7th Ed. Elsevier Saunders, Philadelphia, 2004; pp 1553-1632
-
(2004)
Heart Disease
, pp. 1553-1632
-
-
Bonow, R.O.1
Braunwald, E.2
|